Join the Meeting Place for Moms!
Talk to other moms, share advice, and have fun!

(minimum 6 characters)

And More on Vaccine News and Development

Posted by on May. 24, 2013 at 6:20 AM
  • 0 Replies
  • 143 Total Views

Novartis taps synthetic biology to speed vax development

Read more: Vaccine News | Vaccine Market | Vaccine Research | Fierce Vaccines http://www.fiercevaccines.com/#ixzz2UCifSvq4 
Subscribe at FierceVaccines

  • ndian rotavirus vax set to undercut GSK and Merck

    Having committed to offering its rotavirus vaccine--Rotavac--for $1 a dose in 2011, Indian vaccine manufacturer Bharat Biotech has now presented positive Phase III data that compares favorably to currently available rotavirus vaccines.

Pfizer lays out MRSA vaccine battle plan

Reuters has looked inside the Pfizer lab tasked with developing a vaccine for the drug-resistant superbug MRSA.

UPDATED: NIH makes progress on universal flu vaccine

A universal flu vaccine is the holy grail of influenza immunizations. The yearly process of making educated guesses about the upcoming flu season would end, replaced by a vaccine for many of the strains. It is a massive challenge, but one that Sanofi and others have taken up.

Analyst taps Bristol, Roche cancer immunotherapies for explosive growth

Cancer vaccines have so far generated more headlines than health benefits. Even some of the success stories, like Dendreon, have faltered once faced with trying to commercialize an oncology immunotherapy. Yet the vast potential means people continue to talk up the sector.

Inertia at Pakistan's NIH threatening vaccine programs

Recruiting for vacant senior positions is a balancing act between identifying the ideal person and hiring quickly to avoid a power vacuum. Pakistan's National Institutes of Health (NIH) seems to be struggling to find this balance. Its search for an executive director is now in its fifth year.

Pfizer points to pandemic potential of Prevnar 13

In pandemic flu preparation, a lot of focus is placed on protecting against the specific viral strain. Yet analysis of the 1918 pandemic shows secondary bacterial pneumonia directly caused many of the deaths. This brings Pfizer's Prevnar 13 into play, and the Big Pharma is talking up its role.

MORE NEWS



Read more: Vaccine News | Vaccine Market | Vaccine Research | Fierce Vaccines http://www.fiercevaccines.com/#ixzz2UCijLA8J 
Subscribe at FierceVaccines

by on May. 24, 2013 at 6:20 AM
Add your quick reply below:
You must be a member to reply to this post.
Replies:
There are no replies to this post.
Join the Meeting Place for Moms!
Talk to other moms, share advice, and have fun!

(minimum 6 characters)